FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37422711000001102: Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
326291000001111 Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
326301000001110 Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Is a Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Has specific active ingredient Irbesartan true Inferred relationship Existential restriction modifier
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) 28 tablet Has AMP True Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start